Key facts
- This page summarizes Matthew Francis Pine's Form 4 filing for Xylem Inc. (XYL).
- 9 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2026, 17:02.
Matthew Francis Pine - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)
- Reporting relationship
- Pres. & CEO, Director
- Issuer ticker
- XYL
- Reported as of
- 01 Mar 2026
- Net transaction value
- +$8,249,819
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2026, 17:02:27 UTC
- Prior SEC filing
- 09 Jun 2025
- Next SEC filing
- 06 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mike Nazario, by power of attorney for Matthew Pine
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew Francis Pine filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.
Change
- Previous filing in this sequence was filed on 09 Jun 2025.
- Current net transaction value: +$8,249,819.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001807057
Primary reporting owner
Pine Matthew Francis
- Relationship
- Pres. & CEO, Director
- Address
- C/O XYLEM INC., 301 WATER STREET SE, WASHINGTON
- Signature
- /s/ Mike Nazario, by power of attorney for Matthew Pine
- Signature date
- 03 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XYL
transaction
Common Stock
Award
- Transaction value
- $676,242
- Shares
- +5,243
- Change %
- +22%
- Price
- $128.98
- Shares after
- 29,513
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
XYL
transaction
Common Stock
Award
- Transaction value
- $558,225
- Shares
- +4,328
- Change %
- +15%
- Price
- $128.98
- Shares after
- 33,841
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
XYL
transaction
Common Stock
Award
- Transaction value
- $379,588
- Shares
- +2,943
- Change %
- +8.7%
- Price
- $128.98
- Shares after
- 36,784
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F4
XYL
transaction
Common Stock
Award
- Transaction value
- $277,565
- Shares
- +2,152
- Change %
- +5.9%
- Price
- $128.98
- Shares after
- 38,936
- Date
- 01 Mar 2026
- Ownership
- Direct
- Footnotes
- F5
XYL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +16,105
- Change %
- +41%
- Price
- $0.000000
- Shares after
- 55,041
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F6
XYL
transaction
Common Stock
Tax liability
- Transaction value
- $635,484
- Shares
- -4,927
- Change %
- -9%
- Price
- $128.98
- Shares after
- 50,114
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F7
XYL
transaction
Common Stock
Tax liability
- Transaction value
- $109,246
- Shares
- -847
- Change %
- -1.7%
- Price
- $128.98
- Shares after
- 49,267
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F8
XYL
transaction
Common Stock
Tax liability
- Transaction value
- $298,718
- Shares
- -2,316
- Change %
- -4.7%
- Price
- $128.98
- Shares after
- 46,951
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F9
XYL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 34,007
- Date
- 01 Mar 2026
- Ownership
- Matthew F. Pine and Angeles Lopez Guerrero Living Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XYL
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $7,401,646
- Shares
- +57,386
- Change %
- Price
- $128.98
- Shares after
- 57,386
- Date
- 02 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 57,386
- Exercise price
- $128.98
- Footnotes
- F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 10 footnotes
Footnote F1
Reflects the acquisition of 5,243 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.
Footnote F2
Includes additional shares due to dividend reinvestment.
Footnote F3
Reflects the acquisition of 4,328 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.
Footnote F4
Reflects the acquisition of 2,943 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.
Footnote F5
Reflects the acquisition of 2,152 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.
Footnote F6
Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.
Footnote F7
Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).
Footnote F8
Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).
Footnote F9
Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (649) and March 1, 2024 (1,667) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Footnote F10
Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.